Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
October 29 2021 - 6:09AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2021
HAPPINESS BIOTECH GROUP LIMITED
(Exact name of registrant as specified in its charter)
No. 11, Dongjiao East Road, Shuangxi, Shunchang,
Nanping City
Fujian Province, People’s Republic of
China
+86-0599-782-8808
(Address of Principal Executive Office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form40-F.
Form 20-F ☒ Form40-F ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting
the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Submission of Matters to a Vote of Security Holders.
Happiness Biotech Group Limited (the “Company”)
held its annual meeting of shareholders for its fiscal year ending March 31, 2021 at 10:00 a.m. EST on October 21, 2021 at its principal
executive offices in Fujian, China. Holders of 17,036,540 ordinary shares of the Company were present in person or by proxy at the annual
meeting, representing approximately 53.31% of the total 31,953,025 outstanding ordinary shares and therefore constituting a quorum of
more than one third of the shares outstanding and entitled to vote at the annual meeting as of the record date of August 26, 2021. The
final voting results for each matter submitted to a vote of shareholders at the meeting are as follows:
|
1.
|
That the following constitutes the number of votes voted with respect to the following persons as directors of the Company:
|
Director’s Name
|
|
For
|
|
Against
|
|
Abstain
|
Xuezhu Wang
|
|
16,581,584
|
|
378,043
|
|
76,913
|
|
|
|
|
|
|
|
John Levy
|
|
16,411,967
|
|
491,235
|
|
133,338
|
|
|
|
|
|
|
|
Wenhui Lin
|
|
16,459,182
|
|
483,802
|
|
93,556
|
|
|
|
|
|
|
|
Zhangshu Huang
|
|
16,459,198
|
|
483,843
|
|
93,499
|
|
|
|
|
|
|
|
Lun Liu
|
|
16,459,240
|
|
483,801
|
|
93,499
|
Accordingly, each such person has been duly elected
as a director to hold such office until the 2022 annual meeting of shareholders or until his successor is elected and shall qualify.
|
2.
|
That the following constitutes the number of shares voted with respect to ratification of the appointment of Briggs & Veselka
Co. as the Company’s independent registered public accounting firm for the fiscal year ending March 31, 2022:
|
For
|
|
Against
|
|
Abstain
|
16,805,295
|
|
196,615
|
|
34,630
|
Accordingly, the ratification of the appointment
of Briggs & Veselka Co. as the Company’s independent registered public accounting firm for the fiscal year ending March 31,
2022 has been approved and adopted.
|
3.
|
That the following constitutes the number of shares voted with respect to the approval of the alteration to the share capital of the
Company as set forth in the notice to shareholders.
|
For
|
|
Against
|
|
Abstain
|
15,666,513
|
|
1,317,149
|
|
52,878
|
Accordingly, the alteration to the share capital
of the Company has been approved.
|
4.
|
That the following constitutes the number of shares voted with respect to the approval the change of the Company’s name to “Happiness
Development Group Limited”;
|
For
|
|
Against
|
|
Abstain
|
16,780,892
|
|
177,751
|
|
77,897
|
Accordingly, the change of the Company’s
name to “Happiness Development Group Limited” has been approved.
|
5.
|
That the following constitutes the number of shares voted with respect to the approval the amended and restated memorandum and articles
of association;
|
For
|
|
Against
|
|
Abstain
|
15,990,350
|
|
739,031
|
|
307,159
|
Accordingly, the amended and restated memorandum
and articles of association has been approved.
SIGNATURES
Pursuant to the requirements
of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
Happiness Biotech Group Limited
|
|
|
|
Date: October 28, 2021
|
By:
|
/s/ Xuezhu Wang
|
|
|
Xuezhu Wang
Chief Executive Officer
|
Happiness Development (NASDAQ:HAPP)
Historical Stock Chart
From Aug 2024 to Sep 2024
Happiness Development (NASDAQ:HAPP)
Historical Stock Chart
From Sep 2023 to Sep 2024